Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Fluconazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4 Mycoses 3 Leukemia, Myeloid, Acute 3 Infections 3 Recurrence 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Torulopsis 1 Testicular Neoplasms 1 Teratoma, Testicular 1 Teratoma 1 Stem Cell Transplant Complications 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumours 1 Sezary Syndrome 1 Seminoma 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Nivolumab 15 Surveys and Questionnaires 7 Ipilimumab 7 linrodostat 5 Standard of Care 5 Paclitaxel 5 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Interviews as Topic 4 Gemcitabine 4 Docetaxel 4 relatlimab 3 Vorinostat 3 Pemetrexed 3 Erlotinib Hydrochloride 3 Cetuximab 3 Carboplatin 3 ARRY-334543 3 regorafenib 2 apatinib 2 abemaciclib 2 Trastuzumab 2 Sunitinib 2 Sorafenib 2 Olanzapine 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04193319 2019-12-10

Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡